Celemics, Inc. designs, manufactures, and distributes sequencing kits in South Korea. Its offerings include whole exome sequencing panels, NGS target enrichment panels, customized and ready-to-use enrichment panels, and modular accessories such as library preparation kits, double standard cDNA synthesis, hybridization enhancer, clean-up and streptavidin beads, CeleNM beads, and polymerase. The company also provides services in celemics analysis, whole exome sequencing, customized NGS panels, sequencing, bioinformatics, biopharma, and custom NGS assay development. Its products are used in oncology, liquid biopsy, biopharma solutions, inherited diseases, pharmacogenomics, virus research, agrigenomics, RNA sequencing, epigenetics, metagenomic sequencing, antibody discovery, and bioinformatics applications. Founded in 2010, the company is headquartered in Seoul, South Korea.